Your browser doesn't support javascript.
loading
High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment.
Ma, Jinhu; Zhang, Chunxue; Shi, Gang; Yue, Dan; Shu, Yongheng; Hu, Shichuan; Qi, Zhongbing; Chen, Yanwei; Zhang, Bin; Zhang, Yong; Huang, Anliang; Su, Chao; Zhang, Yan; Deng, Hongxin; Cheng, Ping.
Afiliación
  • Ma J; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Zhang C; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Shi G; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Yue D; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, PR China.
  • Shu Y; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Hu S; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Qi Z; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Chen Y; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Zhang B; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Zhang Y; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Huang A; Department of Pathology, Chengdu Fifth People's Hospital, Chengdu, PR China.
  • Su C; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Zhang Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, PR China.
  • Deng H; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China.
  • Cheng P; State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17 People's South Road, Chengdu 610041, PR China. Electronic address: ping.cheng@foxmail.com.
Mol Ther ; 30(2): 644-661, 2022 02 02.
Article en En | MEDLINE | ID: mdl-34547462
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus Oncolíticos / Viroterapia Oncolítica / Neoplasias Idioma: En Revista: Mol Ther Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus Oncolíticos / Viroterapia Oncolítica / Neoplasias Idioma: En Revista: Mol Ther Año: 2022 Tipo del documento: Article